Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 4
2(33.3%)
6Total
N/A(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04332562Not ApplicableUnknown

The Association Between Serum β-hydroxybutyrate and Levels of Systemic Hypertension

Role: lead

NCT04177979Not ApplicableCompleted

Efficacy of Near-Assisted Learning (NAL) in Improving Students' Objective Structured Clinical Examination (OSCE) Grades

Role: lead

NCT03804801Phase 4Unknown

Effect of Hibiscus Sabdariffa on Blood Pressure in a University Population

Role: lead

NCT03781557Phase 4Unknown

Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels

Role: lead

NCT03776448Not ApplicableUnknown

The Effect of 2 Grams Daily Supplementation of Sativa Nigra Oil on Blood Glucose Levels of Adults.

Role: lead

NCT03447301Not ApplicableUnknown

The Effect of Daily Consumption of Extra Virgin Olive Oil on Blood Glucose Among Diabetic Patients

Role: lead

All 6 trials loaded